INS and obesity disorder: In obesity, elevated levels of insulin/IGF-1 and gastrointestinal peptides that act via their cognate GPCRs, e.g., neurotensin [198], enhance the crosstalk between insulin receptor and GPCR signaling pathways, leading to increased cellular proliferation.